Testosterone Treatment Lawsuits Continue As Attorneys Meet For Case Management Conference, Reports Wright & Schulte LLC

Share Article

Pretrial Proceedings In Testosterone Treatment Lawsuits Are Underway In the U.S. District Court, Northern District Of Illinois Where Testosterone Claims Allege Men Suffered Heart Attacks, Strokes And Deep Vein Thrombosis In Men Who Used Testosterone Replacement Therapy To Treat Hypogonadism

Testosterone Treatment Lawsuit Litigation Alleging Heart Attacks, Strokes, and Blood Clots Move Forward

Testosterone Treatment Lawsuit Litigation Alleging Heart Attacks, Strokes, and Blood Clots Move Forward

If you believe you have experienced a heart attack or stroke due to low testosterone treatment drugs contact the attorneys at Wright & Schulte LLC for a free evaluation by calling 1-800-399-0795 or visit www.yourlegalhelp.com

The attorneys at Wright & Schulte LLC are looking towards the outcome of tomorrows case management conference for testosterone treatment lawsuits alleging heart attacks, strokes and blood clots due to testosterone therapy drugs such as AndroGel, Androderm and other testosterone products. The low testosterone complaints are consolidated in the U.S. District Court, Northern District of Illinois where the conference will be held at 2:30 p.m. on February 20, 2015. The testosterone treatment lawsuits allege that men who use testosterone products such as Axiron and Depo-Testosterone suffer cardiovascular complications and death. The low testosterone treatment complaints accuse testosterone manufacturers of failing to warn physicians and their patients about the risks associated with their testosterone products (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Wright & Schulte LLC continues to investigate claims of serious side-effects after taking low testosterone drugs and offers free testosterone drug lawsuit evaluations to men, or their survivors, who believe they have suffered heart attacks, strokes or death after using low testosterone therapy drugs such as AndroGel, Androderm or Testim. To speak with one of the law firm’s experienced attorneys, call 1-800-399-0795 or visit yourlegalhelp.com for more information on Low-T drug side-effects and other prescription drug information.

According to the multidistrict litigation docket of the U.S. Judicial Panel on Multidistrict Litigation (JPML). In June, the JPML granted a request to consolidate all federally filed testosterone lawsuits for pretrial proceedings. In granting the request, the judicial panel transferred all testosterone lawsuits, regardless of the testosterone manufacturer named as the defendant, to the U.S. District Court, Northern District of Illinois and assigned Judge Matthew F. Kennelly to manage the litigation. The JPML's industrywide consolidation includes testosterone lawsuits filed against:

  • AbbVie Inc. and Abbot Laboratories, which manufactures and markets AndroGel
  • Actavis, Inc. and Watson Pharmaceuticals, manufacturers of AndroDerm 
  • Auxilium Pharmaceuticals, Inc., manufacturer of Testim
  • Endo Pharmaceuticals Inc., which makes Delatestryl and Fortesta
  • Eli Lilly and Company and Lilly USA LLC, the makers of Axiron
  • Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Co.,which makes and markets Depo-Testosterone.


The request to consolidation of low testosterone therapy lawsuits and the spike in testosterone filings came after the U.S. Food and Drug Administration (FDA) announced in January 2014 that it was launching an investigation into the effectiveness and safety of all FDA-approved testosterone products that treat hypogonadism, which is a low level of testosterone in men due to an underlying medical condition. The FDA said it was examining the products after reviewing two observational studies that showed cardiovascular risks associated with testosterone use in older men. The first study, published in the November 2013 Journal of the American Medical Association, found that older men who had underlying cardiovascular disease and took low testosterone treatment had a 30 percent increased risk of having a stroke, heart attack or death compared to men who did not take the low testosterone medication. The second study, published in the PLOS One Journal on January 29, 2014, showed that men over 65 and younger men with a pre-existing heart disease were at a greater risk of having a heart attack within the first 90 days after taking low testosterone drugs for the first time.
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]
[plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805, January 29, 2014]
[jama.jamanetwork.com/article.aspx?articleid=1764051, November 6, 2013]

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free testosterone lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
Like us on Facebook
Follow us on Twitter
Join us on Google+

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Richard Schulte

Corey Artim
Follow us on
Visit website